MACKAY MARTIN has filed 14 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 18055 shares of Rallybio Corp ($RLYB) on February 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Rallybio Corp | $RLYB | MACKAY MARTIN | Director | A | Option (Right to Buy) | 18055 | $3.60 | 18,055.0000 | 45,058,591 | 9999.99% | 0.04% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 815 | $134.98 | 14,292.0000 | 51,201,000 | 6.05% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Stock Options (Right to Buy) | 2076 | $134.98 | 2,076.0000 | 51,201,000 | 9999.99% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 946 | $134.98 | 13,477.0000 | 51,201,000 | 7.55% | 0.00% |
| May 13, 2025 | Rallybio Corp | $RLYB | MACKAY MARTIN | Director | A | Option (Right to Buy) | 28500 | $0.00 | 28,500.0000 | 43,544,824 | 9999.99% | 0.07% |
| Jan. 2, 2025 | Rallybio Corp | $RLYB | MACKAY MARTIN | Director | A | Option (Right to Buy) | 92857 | $0.70 | 92,857.0000 | 43,544,824 | 9999.99% | 0.21% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 372 | $228.41 | 12,531.0000 | 51,552,000 | 3.06% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Stock Options (Right to Buy) | 1311 | $228.41 | 1,311.0000 | 51,552,000 | 9999.99% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 559 | $228.41 | 12,159.0000 | 51,552,000 | 4.82% | 0.00% |
| Feb. 15, 2024 | Rallybio Corp | $RLYB | MACKAY MARTIN | Executive Chairman | A | Option (Right to Buy) | 216000 | $0.00 | 216,000.0000 | 40,447,388 | 9999.99% | 0.53% |
| July 3, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 95 | $0.00 | 11,600.0000 | 50,944,000 | 0.83% | 0.00% |
| May 31, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 338 | $0.00 | 11,505.0000 | 50,944,000 | 3.03% | 0.00% |
| May 15, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Common Stock | 664 | $0.00 | 11,167.0000 | 50,944,000 | 6.32% | 0.00% |
| May 15, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | MACKAY MARTIN | Director | A | Stock Options (Right to Buy) | 1669 | $192.36 | 1,669.0000 | 50,944,000 | 9999.99% | 0.00% |